Recursion Pharmaceuticals, Inc. (RXRX) Ownership

$7.28

north_east
$0.52 (7.66%)
Day's range
$6.71
Day's range
$7.4

Recursion Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ARK INVESTMENT MANAGEMENT LLC 10/31/2024 32.77 M $215.95 M   16.44% 11.60%
BAILLIE GIFFORD & CO 11/05/2024 25.24 M $166.33 M   -5.08% 8.93%
VANGUARD GROUP INC 11/13/2024 24.27 M $159.96 M   12.60% 8.59%
BLACKROCK FUNDING, INC. /DE 11/13/2024 20.74 M $136.70 M   100.00% 7.34%
RA CAPITAL MANAGEMENT, L.P. 11/14/2024 15.38 M $101.38 M   0.00% 5.44%
MUBADALA INVESTMENT CO PJSC 11/13/2024 12.99 M $85.58 M   0.00% 4.60%
STATE STREET CORP 11/14/2024 12.87 M $84.82 M   47.10% 4.55%
KINNEVIK AB (PUBL) 10/15/2024 11.91 M $78.46 M   0.00% 4.21%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 11/05/2024 9.77 M $64.36 M   -2.21% 3.46%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 11/07/2024 9.69 M $63.89 M   -2.41% 3.43%
MIC CAPITAL MANAGEMENT UK LLP 11/14/2024 8.45 M $55.70 M   0.00% 2.99%
FMR LLC 11/13/2024 8.36 M $55.12 M   2.08% 2.96%
NVIDIA CORP 11/14/2024 7.71 M $50.78 M   0.00% 2.73%
DATA COLLECTIVE IV GP, LLC 11/14/2024 5.94 M $39.15 M   0.00% 2.10%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 5.43 M $35.80 M   13.74% 1.92%
DCVC OPPORTUNITY FUND II GP, LLC 11/14/2024 3.95 M $26.04 M   0.00% 1.40%
EXOR CAPITAL LLP 11/13/2024 3.68 M $24.22 M   0.00% 1.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11/14/2024 2.32 M $15.26 M   100.00% 0.82%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 1.94 M $12.79 M   17.49% 0.69%
MORGAN STANLEY 11/14/2024 1.88 M $12.37 M   6.16% 0.66%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 1.72 M $11.32 M   -10.54% 0.61%
TWO SIGMA INVESTMENTS, LP 11/14/2024 1.60 M $10.53 M   11.99% 0.57%
GOLDMAN SACHS GROUP INC 11/14/2024 1.54 M $10.15 M   43.82% 0.54%
JPMORGAN CHASE & CO 12/26/2024 1.18 M $7.75 M   6.08% 0.42%
BANK OF AMERICA CORP /DE/ 11/14/2024 1.17 M $7.68 M   -36.71% 0.41%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 1.12 M $7.41 M   49.81% 0.40%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 1.07 M $7.05 M   -21.73% 0.38%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 1.01 M $6.65 M   -19.62% 0.36%
LIONTRUST INVESTMENT PARTNERS LLP 10/16/2024 990,000 $7.43 M   0.00% 0.35%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 11/14/2024 973,583 $6.42 M   100.00% 0.34%
COMPREHENSIVE FINANCIAL MANAGEMENT LLC 11/14/2024 941,895 $6.21 M   0.00% 0.33%
BANK OF NEW YORK MELLON CORP 11/12/2024 926,118 $6.10 M   -12.70% 0.33%
UBS GROUP AG 11/14/2024 799,860 $5.27 M   -51.50% 0.28%
VESTMARK ADVISORY SOLUTIONS, INC. 11/14/2024 732,933 $4.83 M   -6.62% 0.26%
BARCLAYS PLC 11/19/2024 697,432 $4.60 M   77.39% 0.25%
CERCANO MANAGEMENT LLC 11/14/2024 685,018 $4.51 M   0.00% 0.24%
RAFFERTY ASSET MANAGEMENT, LLC 11/13/2024 675,791 $4.45 M   52.12% 0.24%
WOODLINE PARTNERS LP 11/14/2024 671,319 $4.42 M   1.03% 0.24%
LAZARD ASSET MANAGEMENT LLC 11/14/2024 642,308 $4.23 M   22.54% 0.23%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 591,500 $3.90 M   94.89% 0.21%
CITADEL ADVISORS LLC 11/14/2024 556,700 $3.67 M   1.20% 0.20%
TWINBEECH CAPITAL LP 11/14/2024 535,079 $3.53 M   44.13% 0.19%
TWO SIGMA ADVISERS, LP 11/14/2024 489,900 $3.23 M   12.41% 0.17%
ENSIGN PEAK ADVISORS, INC 11/14/2024 408,986 $2.70 M   0.00% 0.14%
BELLEVUE GROUP AG 11/14/2024 392,881 $2.59 M   -7.73% 0.14%
LPL FINANCIAL LLC 11/08/2024 360,438 $2.38 M   12.82% 0.13%
SWISS NATIONAL BANK 11/07/2024 357,100 $2.35 M   0.53% 0.13%
RHUMBLINE ADVISERS 11/12/2024 310,468 $2.05 M   10.35% 0.11%
CITADEL ADVISORS LLC 11/14/2024 299,300 $1.97 M   16.73% 0.11%
SIMPLEX TRADING, LLC 11/08/2024 284,713 $1.88 M   200.42% 0.10%

Recursion Pharmaceuticals, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of RXRX shares?

During the previous two years, 316 institutional investors and hedge funds held shares of Recursion Pharmaceuticals, Inc.. The most heavily invested institutionals were:

ARK Investment Management LLC: 32.77 M

BAILLIE GIFFORD & CO: 25.24 M

VANGUARD GROUP INC: 24.27 M

BlackRock Funding, Inc. /DE: 20.74 M

RA CAPITAL MANAGEMENT, L.P.: 15.38 M

Mubadala Investment Co PJSC: 12.99 M

What percentage of Recursion Pharmaceuticals, Inc. stock is owned by institutional investors?

92.33% of Recursion Pharmaceuticals, Inc. stock is owned by institutional investors.

How much institutional buying is happening at RXRX ?

Institutional investors have bought a total of 284.90 M shares in the last 24 months. This purchase volume represents approximately $2.07 B in transactions.